Indication
Actinomycosis
Actinomycosis is a rare, subacute to chronic, slowly progressive bacterial infection primarily caused by anaerobic or microaerophilic, filamentous, Gram-positive species of the genus *Actinomyces*, most notably *Actinomyces israelii*. Read more about Actinomycosis
237 drugs 118 manufacturers
Drugs that treat it
Common Actinomycosis therapies.
DYNACIN (minocycline HCl)
MONODOX (doxycycline monohydrate)
VIBRAMYCIN (doxycycline hyclate)
VIBRAMYCIN (doxycycline calcium)
ADOXA (doxycycline monohydrate)
ADOXA (doxycycline monohydrate)
TERRAMYCIN IM (oxytetracycline)
MORGIDOX (doxycycline hyclate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonActinomycosis is a rare, subacute to chronic, slowly progressive bacterial infection primarily caused by anaerobic or microaerophilic, filamentous, Gram-positive species of the genus *Actinomyces*, most notably *Actinomyces israelii*.
Typically an endogenous infection triggered by mucosal barrier disruption from trauma, dental disease, surgery, or foreign bodies, it most commonly affects the cervicofacial region, though thoracic, abdominopelvic, and central nervous system involvement can also occur.
Pathophysiologically, it is characterized by contiguous tissue invasion that disregards tissue planes, producing indurated granulomatous lesions, extensive fibrosis, multiple abscesses, and draining sinus tracts that classically extrude macroscopic macroscopic bacterial colonies known as sulfur granules.
- nih.gov
Actinomycosis is a rare, subacute to chronic, slowly progressive bacterial infection primarily caused by anaerobic or microaerophilic, filamentous, Gram-positive species of the genus *Actinomyces*, most notably *Actinomyces israelii* Pathophysiologically, it is characterized by contiguous tissue invasion that disregards tissue planes, producing indurated granulomatous lesions, extensive fibrosis, multiple abscesses, and draining sinus tracts that classically extrude macroscopic macroscopic bacte...
- merckmanuals.com
Actinomycosis is a rare, subacute to chronic, slowly progressive bacterial infection primarily caused by anaerobic or microaerophilic, filamentous, Gram-positive species of the genus *Actinomyces*, most notably *Actinomyces israelii* Typically an endogenous infection triggered by mucosal barrier disruption from trauma, dental disease, surgery, or foreign bodies, it most commonly affects the cervicofacial region, though thoracic, abdominopelvic, and central nervous system involvement can also occ...
- nih.gov
Typically an endogenous infection triggered by mucosal barrier disruption from trauma, dental disease, surgery, or foreign bodies, it most commonly affects the cervicofacial region, though thoracic, abdominopelvic, and central nervous system involvement can also occur Pathophysiologically, it is characterized by contiguous tissue invasion that disregards tissue planes, producing indurated granulomatous lesions, extensive fibrosis, multiple abscesses, and draining sinus tracts that classically ex...
- nih.gov
Typically an endogenous infection triggered by mucosal barrier disruption from trauma, dental disease, surgery, or foreign bodies, it most commonly affects the cervicofacial region, though thoracic, abdominopelvic, and central nervous system involvement can also occur
Personalize your experience
Follow Actinomycosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.